<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[SurModics Inc. | Company News & Executive Profiles - SRDX | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/surmodics+inc..html]]></link>
	<description><![CDATA[Latest company news & analysis, recent events, stock quotes, earning call transcripts, with profiles and descriptions of top business executives for SurModics Inc.]]></description>
	<s:counts start="0" returned="10" found="24" />
	<language>en-us</language>
	<item>
		<title><![CDATA[SurModics, Inc.Q4 2009 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-13071_23-361070.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator  Operator Instructions Your first question comes from Richard Rinkoff with Craig-Hallum Group.   Richard Rinkoff - Craig-Hallum Group I want to clarify something; did you say that you received $1.25 million in basically back payments from Abbott in the fourth quarter? Philip Ankeny Yes, essentially....]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<pubDate>Wed, 04 Nov 2009 16:29:07 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/r%2526d.html"><![CDATA[R&D]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/research+%2526+development.html"><![CDATA[Research & Development]]></category>
		<category domain="http://resources.bnet.com/topic/business+operations.html"><![CDATA[Business Operations]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://resources.bnet.com/topic/surmodics+inc..html"><![CDATA[SurModics Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SRDX</category>
		<category domain="tickers">SRDX</category>
	</item>
	<item>
		<title><![CDATA[SurModics Q2 2009 Earnings Transcript]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F152386-surmodics-q2-2009-earnings-transcript%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[SurModics, Inc. SRDX   Q3 2009 Earnings Call   June 29, 2009 05:00 AM ET]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Thu, 30 Jul 2009 01:19:11 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/surmodics+inc..html"><![CDATA[SurModics Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SRDX</category>
		<category domain="tickers">SRDX</category>
	</item>
	<item>
		<title><![CDATA[SurModics Q2 2009 Earnings Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-13071_23-326467.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Thank you sir. We will now begin the question-and-answer session. Operator Instructions. And our first question is from Ross Taylor from CL Kings. Please go ahead. Ross Taylor - CL Kings & Associates I have two or three questions. First related to some of the financials, R&D...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<pubDate>Thu, 30 Jul 2009 00:19:11 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/r%2526d.html"><![CDATA[R&D]]></category>
		<category domain="http://resources.bnet.com/topic/question.html"><![CDATA[Question]]></category>
		<category domain="http://resources.bnet.com/topic/research+%2526+development.html"><![CDATA[Research & Development]]></category>
		<category domain="http://resources.bnet.com/topic/product+development.html"><![CDATA[Product Development]]></category>
		<category domain="http://resources.bnet.com/topic/product+marketing.html"><![CDATA[Product Marketing]]></category>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/business+operations.html"><![CDATA[Business Operations]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[Marketing]]></category>
		<category domain="http://resources.bnet.com/topic/management.html"><![CDATA[Management]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://resources.bnet.com/topic/surmodics+inc..html"><![CDATA[SurModics Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SRDX</category>
		<category domain="tickers">SRDX</category>
	</item>
	<item>
		<title><![CDATA[SurModics Inc. F2Q09 (Qtr End 03/31/09) Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-13071_23-293537.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator instructions Our first question is from the line of Rick Rinkoff with Craig-Hallum. Rick Rinkoff &#8211; Craig-Hallum Well, congratulations on a better quarter than one before that. I had a couple of questions here, first of all you said the R&D includes a little bit of...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<pubDate>Thu, 30 Apr 2009 03:25:30 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/merck+%2526+co.+inc..html"><![CDATA[Merck & Co. Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/surmodics+inc..html"><![CDATA[SurModics Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/craig-hallum.html"><![CDATA[Craig-Hallum]]></category>
		<category domain="http://resources.bnet.com/topic/research+%2526+development.html"><![CDATA[Research & Development]]></category>
		<category domain="http://resources.bnet.com/topic/business+operations.html"><![CDATA[Business Operations]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MRK</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SRDX</category>
		<category domain="tickers">MRK,SRDX</category>
	</item>
	<item>
		<title><![CDATA[SurModics, Inc. F1Q09 (Qtr End 12/31/08) Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-13071_23-264688.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Thank you, sir. Ladies and gentlemen we will now begin the question-and-answer session. Operator instructions. Our first question comes from the line of Ross Taylor with C.L. King, please go ahead. Ross Taylor &#8211; C.L. King & Associates, Inc. Hi. I got a couple of questions. First,...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<pubDate>Wed, 28 Jan 2009 16:32:13 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/revenue.html"><![CDATA[Revenue]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/quarter.html"><![CDATA[Quarter]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/surmodics+inc..html"><![CDATA[SurModics Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/public+relations.html"><![CDATA[Public Relations]]></category>
		<category domain="http://resources.bnet.com/topic/operational+accounting.html"><![CDATA[Operational Accounting]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[Marketing]]></category>
		<category domain="http://resources.bnet.com/topic/corporate+communications.html"><![CDATA[Corporate Communications]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SRDX</category>
		<category domain="tickers">SRDX</category>
	</item>
	<item>
		<title><![CDATA[SurModics, Inc. F4Q08 (Qtr End 09/30/08) Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-13071_23-251997.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator instructions And our first question comes from the line of Ross Taylor with C.L. King; please go ahead. Ross Taylor &#8211; C.L. King Hi, I&#8217;ve got a couple of questions. I&#8217;ll try to keep them brief. First of all, why did the Abbott revenues dropped so...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<pubDate>Mon, 24 Nov 2008 08:29:17 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/patent.html"><![CDATA[Patent]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/surmodics+inc..html"><![CDATA[SurModics Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SRDX</category>
		<category domain="tickers">SRDX</category>
	</item>
	<item>
		<title><![CDATA[SurModics Inc. F3Q08 (Qtr End 6/30/08) Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-13071_23-225265.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Thank you, sir. Operator Instructions And our first question comes from Steve Ogilvie with ThinkEquity. Go ahead please. Steve Ogilvie - ThinkEquity Hey, guys. Just a few accounting things to get out of the way first, could you clarify on the $9 million payment, you said it's...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<pubDate>Mon, 28 Jul 2008 12:45:25 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/surmodics+inc..html"><![CDATA[SurModics Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SRDX</category>
		<category domain="tickers">SRDX</category>
	</item>
	<item>
		<title><![CDATA[SurModics Inc. F2Q08 (03/31/08) Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-13071_23-227980.html]]></link>
		<description><![CDATA[ Question-and-Answer Session Operator Thank you, sir. Operator Instructions. Our first question comes from the line of Richard Rinkoff with Craig-Hallum. Please go ahead. Richard Rinkoff - Craig-Hallum Thank you. On the orthopedic product, did any money change hands when you terminated the agreement, and are you considering doing clinical...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<pubDate>Mon, 28 Apr 2008 07:06:09 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/surmodics+inc..html"><![CDATA[SurModics Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SRDX</category>
		<category domain="tickers">SRDX</category>
	</item>
	<item>
		<title><![CDATA[SurModics to Present at the 2008 Association for Research in Vision and Ophthalmology Meeting]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_April_24/ai_n25355753]]></link>
		<description><![CDATA[EDEN PRAIRIE, Minn. -- SurModics, Inc. (Nasdaq: SRDX), a leading provider of surface modification and drug delivery technologies to the healthcare industry, announced today that two posters and one paper will be presented at the 2008 Association for Research in Vision and Ophthalmology ARVO Meeting being held April 27 -...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 24 Apr 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/internet.html"><![CDATA[INTERNET]]></category>
		<category domain="http://resources.bnet.com/topic/sec.html"><![CDATA[SEC]]></category>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/surmodics+inc..html"><![CDATA[SurModics Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/vision.html"><![CDATA[vision]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SRDX</category>
		<category domain="tickers">SRDX</category>
	</item>
	<item>
		<title><![CDATA[SurModics F1Q08 (Qtr End 12/31/07) Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-13071_23-231094.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator We will now begin the question-and-answer session. Operator Instructions Our first question comes from the line of Richard Rinkoff with Craig-Hallum. Please go ahead. Richard Rinkoff - Craig-Hallum Thank you. A couple of questions. Orthopedic: anything new there? Bruce Barclay Continues to progress actively in terms of...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<pubDate>Wed, 23 Jan 2008 20:00:01 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/surmodics+inc..html"><![CDATA[SurModics Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SRDX</category>
		<category domain="tickers">SRDX</category>
	</item>
</channel>
</rss>
